United States: Yearly Stock Market Performance Insight - 2017

Yearly Gainers
2,077
Yearly Losers
1,190
Average Return
20.96%
Total Stocks
3,466
View Detailed Market Cap Breakdown
Market CapYearly GainersYearly LosersAverage ReturnTotal Stocks
Mega Cap 40 5 28.42% 45
Large Cap 507 95 26.04% 610
Mid Cap 478 214 21.62% 718
Small Cap 173 135 18.30% 331

Yearly Streak Leaders for 2017

Stock Streak Streak Return
9 years โ†‘ 725.69%

UnitedHealth continues its impressive multi-year expansion with a 9-year growth streak (26.70 โ†’ 220.46), delivering 725.7% cumulative returns. With 109.6B annual revenue generating only 6.5B profit (5.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

9 years โ†‘ 721.54%

Home Depot continues its impressive multi-year expansion with a 9-year growth streak (23.07 โ†’ 189.53), delivering 721.5% cumulative returns. Financial performance supports steady gains with 39.9B annual revenue yielding 3.4B profit (Qtr ending Apr 2025). The 8.6% margin provides buffer for continued expansion.

1 years โ†“ -44.90%

General Electric records negative returns with a 1-year decline (151.78 โ†’ 83.63), down 44.9% cumulatively. Yet fundamentals remain solid: 9.9B annual revenue generating 2.0B profit (19.9% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

1 years โ†“ -9.98%

Advanced Micro records negative returns with a 1-year decline (11.42 โ†’ 10.28), down 10.0% cumulatively. Weak margins on 7.4B annual revenue with only 709.0M profit (9.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

12 years โ†‘ 505.92%

Church & Dwight continues its impressive multi-year expansion with a 12-year growth streak (8.28 โ†’ 50.17), delivering 505.9% cumulative returns. Annual financials validate this performance: 1.5B revenue generating 220.1M net profit (15.0% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

10 years โ†‘ 1,159.81%

Ross Stores continues its impressive multi-year expansion with a 10-year growth streak (6.37 โ†’ 80.25), delivering 1,159.8% cumulative returns. Financial performance supports steady gains with 5.0B annual revenue yielding 479.2M profit (Qtr ending Apr 2025). The 9.6% margin provides buffer for continued expansion.

4 years โ†“ -63.47%

Gamestop faces prolonged challenges with a 4-year decline (12.29 โ†’ 4.49), down 63.5% cumulatively. Weak margins on 732.4M annual revenue with only 44.8M profit (6.1% margin) in Qtr ending Apr 2025 validate market skepticism. Structural improvements needed before recovery.

3 years โ†“ -57.87%

Chipotle Mexican sees continued yearly losses with a 3-year decline (13.72 โ†’ 5.78), down 57.9% cumulatively. Annual revenue of 2.9B provides stability, but 386.6M net income (13.4% margin) in Qtr ending Mar 2025 highlights operational challenges requiring strategic shifts.

10 years โ†‘ 385.23%

J & J Snack Foods solidifies its market leadership with a 10-year growth streak (31.29 โ†’ 151.83), delivering 385.2% cumulative returns. With 356.1M annual revenue generating only 4.8M profit (1.4% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

9 years โ†‘ 4,366.67%

Sirius XM Holdings demonstrates exceptional long-term growth with a 9-year growth streak (1.20 โ†’ 53.60), delivering 4,366.7% cumulative returns. Robust fundamentals support sustained growth: 2.1B annual revenue and 204.0M net income (Qtr ending Mar 2025) showcase strong pricing power that compounds over years.

7 years โ†“ -92.57%

Northern Oil and Gas faces prolonged challenges with a 7-year decline (275.80 โ†’ 20.50), down 92.6% cumulatively. Yet fundamentals remain solid: 580.3M annual revenue generating 139.0M profit (23.9% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

4 years โ†“ -99.43%

Civitas Resources faces prolonged challenges with a 4-year decline (4,808.33 โ†’ 27.59), down 99.4% cumulatively. Yet fundamentals remain solid: 1.2B annual revenue generating 186.0M profit (15.6% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

10 years โ†‘ 1,563.72%

Eplus demonstrates exceptional long-term growth with a 10-year growth streak (2.26 โ†’ 37.60), delivering 1,563.7% cumulative returns. With 498.1M annual revenue generating only 25.2M profit (5.1% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

10 years โ†‘ 482.67%

Standex continues its impressive multi-year expansion with a 10-year growth streak (17.48 โ†’ 101.85), delivering 482.7% cumulative returns. Annual financials validate this performance: 207.8M revenue generating 22.7M net profit (10.9% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

4 years โ†“ -99.09%

Tandem Diabetes Care endures extended market pressure with a 4-year decline (259.40 โ†’ 2.36), down 99.1% cumulatively. Financial struggles compound yearly losses: despite 234.4M annual revenue, - 130.6M losses persist (-55.7% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

4 years โ†“ -82.75%

Universal Technical faces prolonged challenges with a 4-year decline (13.91 โ†’ 2.40), down 82.7% cumulatively. Weak margins on 207.4M annual revenue with only 11.4M profit (5.5% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

United States Market Yearly Gainers & Losers: 2017

Top United States Stock Gainers (2017)

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYear Volume
$2.61 $4.84 81.27% 683.14M 172.15B
$75.31 $130.39 75.40% 1.58M 398.40M
$37.90 $58.47 55.96% 70.06M 17.65B
$124.96 $191.96 55.06% 6.56M 1.65B
$62.92 $96.71 54.44% 5.97M 1.50B
$3.64 $18.93 421.49% 6.58K 1.66M
$13.61 $52.54 293.26% 2.40M 604.74M
$38.15 $127.05 239.34% 1.13M 284.78M
$1.21 $3.08 165.52% 353.39K 89.05M
$13.82 $34.67 154.37% 9.41M 2.37B
$3.61 $28.40 639.58% 1.45M 365.76M
$14.95 $91.79 516.04% 69.37K 17.48M
$0.20 $0.80 300.00% 199 50.16K
$1.04 $3.91 272.38% 977.80K 246.41M
$14.25 $51.30 266.43% 1.04M 261.25M
$1.50 $1.50 837.50% 7.98K 2.01M
$4.00 $18.70 373.42% 1.82M 458.95M
$8.90 $33.27 279.36% 74.99K 18.90M
$1.62 $6.00 272.67% 103.10K 25.98M
$6.50 $23.60 263.08% 264.36K 66.62M

Biggest United States Stock Losers (2017)

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYear Volume
$151.78 $83.63 -44.78% 9.58M 2.42B
$11.42 $10.28 -9.35% 64.90M 16.36B
$32.24 $29.37 -8.56% 33.40M 8.42B
$159.66 $146.67 -7.57% 4.45M 1.12B
$90.94 $83.64 -7.33% 10.91M 2.75B
$75.81 $33.93 -54.78% 1.21M 304.27M
$65.29 $31.64 -51.30% 3.25M 819.80M
$33.61 $17.06 -50.35% 5.94M 1.50B
$53.47 $28.74 -45.88% 3.03M 764.81M
$15.33 $9.13 -39.66% 4.16M 1.05B
$0.08 $0.09 -99.12% 2.12K 533.92K
$2.14 $0.05 -97.47% 48 12.20K
$112.58 $24.40 -77.82% 98.77K 24.89M
$117.17 $27.59 -75.76% 184.91K 46.60M
$7.50 $1.87 -74.80% 697.32K 175.73M
$22.00 $2.36 -89.02% 202.93K 51.14M
$3.45 $3.12 -85.86% 637 160.52K
$14.01 $5.13 -63.23% 197.52K 49.78M
$340.50 $151.00 -55.13% 234.66K 59.13M
$7.33 $3.63 -50.75% 144.88K 36.51M

Most Active United States Stocks During 2017

StockYear OpenYear CloseYearly ChangeAvg Daily VolumeYearly Volume
$2.61 $4.84 81.27% 683.14M 172.15B
$28.95 $42.31 46.15% 108.11M 27.24B
$14.32 $20.76 45.68% 94.64M 23.85B
$22.60 $29.52 33.57% 78.56M 19.80B
$37.90 $58.47 55.96% 70.06M 17.65B
$7.58 $5.78 -23.44% 57.97M 14.61B
$12.20 $12.49 2.97% 36.88M 9.29B
$22.07 $41.12 87.59% 30.41M 7.66B
$12.05 $18.34 53.09% 25.86M 6.52B
$36.61 $46.16 27.27% 23.81M 6.00B
$14.69 $20.78 43.11% 18.17M 4.58B
$8.59 $7.21 -14.27% 14.00M 3.53B
$15.15 $10.68 -27.54% 13.53M 3.41B
$24.35 $16.68 -29.86% 11.16M 2.81B
$36.13 $25.19 -29.66% 10.18M 2.57B
$6.09 $5.83 -3.80% 7.92M 1.99B
$1.20 $2.36 96.67% 6.91M 1.74B
$22.66 $22.34 -0.36% 5.73M 1.44B
$21.90 $20.91 -3.06% 5.30M 1.34B
$15.38 $18.80 23.93% 4.54M 1.15B

United States Sector Performance During 2017

Healthcare

31.82%
600 stocks
Top Performers by Market Cap:

Technology

31.02%
442 stocks
Top Performers by Market Cap:
Mega Cap: NVDA +81.27%
Large Cap: SQ +154.37%
Small Cap: UCTT +138.04%

Consumer Cyclical

25.27%
366 stocks
Top Performers by Market Cap:
Mega Cap: AMZN +55.96%
Large Cap: NVR +110.20%
Small Cap: SG +837.50%

Industrials

19.43%
466 stocks
Top Performers by Market Cap:
Mega Cap: GE -44.78%
Large Cap: FER +421.49%
Small Cap: GIC +279.36%

Financial Services

18.72%
613 stocks
Top Performers by Market Cap:
Mega Cap: MA +46.60%
Large Cap: PYPL +86.52%
Small Cap: FBMS +61.22%

Basic Materials

16.94%
201 stocks
Top Performers by Market Cap:
Mega Cap: LIN +31.99%
Large Cap: SHW +52.58%
Mid Cap: AA +91.84%
Small Cap: CENX +129.44%

Utilities

15.74%
74 stocks
Top Performers by Market Cap:
Large Cap: NRG +132.30%
Mid Cap: KEN +85.84%
Small Cap: SJW +14.02%

Communication Services

11.34%
140 stocks
Top Performers by Market Cap:
Mega Cap: NFLX +55.06%
Large Cap: TTWO +122.72%
Mid Cap: IAC +88.69%
Small Cap: GRPN +53.61%

Consumer Defensive

10.55%
145 stocks
Top Performers by Market Cap:
Mega Cap: WMT +42.88%
Large Cap: CELH +113.41%
Small Cap: SPB +8.93%

Real Estate

8.76%
198 stocks
Top Performers by Market Cap:
Large Cap: SBAC +58.20%
Small Cap: IIPR +77.63%

Energy

-3.51%
161 stocks
Top Performers by Market Cap:
Mega Cap: SHEL +22.67%
Large Cap: VG +48.47%
Mid Cap: UEC +58.04%
Small Cap: DK +45.16%

Data is updated regularly. Yearly performance is calculated based on closing prices.